SeaStar Medical (NASDAQ: ICU)

SeaStar Medical (NASDAQ: ICU) is developing and commercializing innovative solutions for the consequences of hyperinflammation. The Company has key near-term milestones that includes the potential FDA approval and commercial launch in its first indication, which is the treatment of critically ill children with acute kidney injury. SeaStar Medical has a world-class team that is focused on improving patient outcomes and saving lives. Keynote speaker: Eric Schlorff, President / CEO & Director